March 19, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for ...

Operator: Greetings. And welcome to the Tenon Medical Fourth Quarter and Full Year 2024 Financial Results and Corporate ...

National Development Bank PLC (NDB) conducted its Investor and Analysts Earnings Call on 12th of March, following the release ...

Power Corporation of Canada (Power Corporation or the Corporation) (TSX: POW) (TSX: POW.PR.E) today reported earnings results for the three and twelve months ended December 31, 2024.

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...

March 19, 2025 - Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on ...

Q4 2024 Results Conference Call March 20, 2025 9:00 AM ETCompany ParticipantsStefanie Zimmermann - Vice President, ...

Revenues Increased 21% and Gross Profit Increased 56% Generated Fourth Quarter Adjusted EBITDA of $1.1 Million ADT Acquisition ...

On October 17, 2024, the Corporation voluntarily repaid the outstanding principal on both the Fixed Rate Construction Facility and the Bank Term Facility #1, for a total principal repayment of $49.9 ...

Q4 2024 Earnings Call Transcript March 20, 2025 Operator: Greetings. Welcome to Gambling.com Group Fourth 2024 Earnings ...

Q4 2025 Earnings Call Transcript March 20, 2025 Planet Labs PBC misses on earnings expectations. Reported EPS is $-0.08 EPS, ...